LivaNova (LIVN) Non-Current Deferred Tax Liability (2015 - 2026)

LivaNova (LIVN) reported Non-Current Deferred Tax Liability of $6.8 million for Q1 2026, down 35.89% on a YoY basis from $10.6 million in Q1 2025, and down 28.97% sequentially from $9.6 million in Q4 2025.

LivaNova (LIVN) Non-Current Deferred Tax Liability (2015 - 2026) Analysis & Trends

LivaNova (LIVN) has 12 years of Non-Current Deferred Tax Liability data on file, last reported at $6.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Deferred Tax Liability fell 35.89% year-over-year to $6.8 million; the trailing twelve-month figure through Mar 2026 stood at $6.8 million (down 35.89% YoY), and the FY2025 full-year result was $9.6 million, down 85.25% from the prior year.
  • Non-Current Deferred Tax Liability eased to $6.8 million in Q1 2026, from $9.6 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $89.2 million in Q4 2022 to a low of $6.5 million in Q3 2022.
  • A 5-year average of $20.5 million and a median of $10.1 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
  • Across the five-year window, Non-Current Deferred Tax Liability soared 1054.62% in 2022 and sank 85.25% in 2025, its largest moves.
  • Tracing LIVN's Non-Current Deferred Tax Liability over 5 years: stood at $89.2 million in 2022, then plunged by 30.34% to $62.2 million in 2023, then gained by 4.62% to $65.0 million in 2024, then slumped by 85.25% to $9.6 million in 2025, then declined by 28.97% to $6.8 million in 2026.
  • Business Quant data shows LIVN's Non-Current Deferred Tax Liability at $6.8 million in Q1 2026, $9.6 million in Q4 2025, and $10.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 LivaNova 4.30 Bn 3.76 Bn 243.75 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.81 Mn
Mar 31, 2026 6.81 Mn
Dec 31, 2025 9.59 Mn
Dec 31, 2025 9.59 Mn
Sep 30, 2025 10.10 Mn
Sep 30, 2025 10.10 Mn
Jun 30, 2025 11.39 Mn
Jun 30, 2025 11.39 Mn
Mar 31, 2025 10.63 Mn
Mar 31, 2025 10.63 Mn
Dec 31, 2024 65.03 Mn
Dec 31, 2024 65.03 Mn
Sep 30, 2024 11.84 Mn
Sep 30, 2024 11.84 Mn
Jun 30, 2024 10.84 Mn
Jun 30, 2024 10.84 Mn
Mar 31, 2024 10.97 Mn
Mar 31, 2024 10.97 Mn
Dec 31, 2023 62.16 Mn
Dec 31, 2023 62.16 Mn